Used in pharmaceutical research as a potent and selective adenosine A2A receptor antagonist. It shows promise in the development of treatments for neurological disorders, particularly Parkinson’s disease, by enhancing motor function and reducing motor deficits without inducing dyskinesia. Its structure allows for good brain penetration, making it suitable for central nervous system targets. Also investigated for potential use in cancer immunotherapy due to the role of A2A receptors in modulating immune responses. Commonly employed as a lead compound in structure-activity relationship (SAR) studies to optimize potency, selectivity, and pharmacokinetic properties in drug discovery programs.